Exploring the science, clinical application, and impact of Ofatumumab in treating advanced-stage chronic lymphocytic leukemia through the UK compassionate use program.
Exploring the promising yet challenging results of dual targeting BTK and CD52 in treating poor-prognosis chronic lymphocytic leukemia
Exploring the potential of Apela protein as a novel therapeutic target for Chronic Lymphocytic Leukemia (CLL) treatment.